Literature DB >> 31663689

Primary congenital glaucoma in Denmark, 1977-2016.

Karen B Pedersen1, Per Kappelgaard1, Line Kessel1,2, Lisbeth Sandfeld3, Nathalie Zibrandtsen4, Daniella Bach-Holm1,2.   

Abstract

PURPOSE: To perform an epidemiological survey of all patients in Denmark diagnosed with primary congenital glaucoma (PCG) from 1977 to 2016.
METHODS: A retrospective, nationwide study based on a review of medical files of all children with PCG born in Denmark from 1977 to 2016. PCG was defined as glaucoma due to isolated angle dysgenesis affecting children from birth and including late onset/late recognized PCG, excluding glaucoma associated with other congenital abnormalities. Incidence and risk factors of PCG including gender, consanguinity, family history, ethnicity, comorbidity and prematurity were evaluated and stratified by decade (1977-1986, 1987-1996, 1997-2006 and 2007-2016). Age at first symptoms, age at diagnosis, age at time of first surgery and possible diagnostic delay were assessed.
RESULTS: Of 118 patients were identified, annual incidence of PCG was 4.8 per 100 000 live born. 62.3% of cases were bilateral. The relative risk (RR) of PCG was significantly higher in boys (62.7% of patients, RR 1.60 (95% CI 1.10-2.32)). 13.6% had comorbidity. Median age at time of first symptoms was 75 days, median age at time of diagnosis was 150 days and median diagnostic delay was 75 days with no significant difference throughout the decades. Unilateral cases presented symptoms and were diagnosed significantly later than bilateral cases.
CONCLUSION: We provide unique nation-based information on the incidence of PCG from a single country covering 40 years. Male gender was a risk factor. Diagnostic delay was unchanged throughout the 4 decades and a high percentage of comorbidity was revealed. Introducing a standardized paediatric screening of all PCG children should be considered.
© 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  comorbidity; diagnostic delay; epidemiology; incidence; primary congenital glaucoma; primary paediatric glaucoma

Mesh:

Year:  2019        PMID: 31663689     DOI: 10.1111/aos.14207

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Long-term structural and functional outcomes of primary congenital glaucoma.

Authors:  Yun Hsia; Tso-Ting Lai; Chien-Chia Su; Tsing-Hong Wang; Jehn-Yu Huang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-22       Impact factor: 3.117

2.  The Epidemiological and Clinical Findings from the Latvian Registry of Primary Congenital Glaucoma and Evaluation of Prognostic Factors.

Authors:  Eva Elksne; Kristine Baumane; Arturs Ozolins; Sandra Valeina
Journal:  Medicina (Kaunas)       Date:  2021-01-07       Impact factor: 2.430

3.  First Results from the Prospective German Registry for Childhood Glaucoma: Phenotype-Genotype Association.

Authors:  Julia V Stingl; Stefan Diederich; Heidi Diel; Alexander K Schuster; Felix M Wagner; Panagiotis Chronopoulos; Fidan Aghayeva; Franz Grehn; Jennifer Winter; Susann Schweiger; Esther M Hoffmann
Journal:  J Clin Med       Date:  2021-12-21       Impact factor: 4.241

4.  Survival of children with rare structural congenital anomalies: a multi-registry cohort study.

Authors:  Alessio Coi; Michele Santoro; Anna Pierini; Judith Rankin; Svetlana V Glinianaia; Joachim Tan; Abigail-Kate Reid; Ester Garne; Maria Loane; Joanne Given; Elisa Ballardini; Clara Cavero-Carbonell; Hermien E K de Walle; Miriam Gatt; Laura García-Villodre; Mika Gissler; Sue Jordan; Sonja Kiuru-Kuhlefelt; Stine Kjaer Urhoj; Kari Klungsøyr; Nathalie Lelong; L Renée Lutke; Amanda J Neville; Makan Rahshenas; Ieuan Scanlon; Diana Wellesley; Joan K Morris
Journal:  Orphanet J Rare Dis       Date:  2022-03-29       Impact factor: 4.123

5.  Circumferential (360°) trabeculotomy in primary congenital glaucoma: 19-245 months of follow-up.

Authors:  Turid Skei Tønset; Jan Erik Jakobsen; Jon Henrik Tveit; Anna-Katharina L Jørstad; Tone Beate Brevik; Lotte-Guri Bogfjellmo Sten; Liv Drolsum
Journal:  Acta Ophthalmol       Date:  2021-03-19       Impact factor: 3.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.